Birchview Capital as of March 31, 2021
Portfolio Holdings for Birchview Capital
Birchview Capital holds 54 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 29.8 | $50M | 794k | 63.13 | |
| Biodesix (BDSX) | 13.3 | $22M | 1.1M | 20.31 | |
| Accelr8 Technology | 10.9 | $18M | 2.2M | 8.31 | |
| Neurocrine Biosciences (NBIX) | 4.6 | $7.8M | 80k | 97.24 | |
| Quidel Corporation | 4.5 | $7.5M | 59k | 127.92 | |
| ACADIA Pharmaceuticals (ACAD) | 2.7 | $4.6M | 177k | 25.80 | |
| Foghorn Therapeutics (FHTX) | 2.5 | $4.1M | 314k | 13.18 | |
| Albireo Pharma | 2.3 | $3.9M | 111k | 35.25 | |
| Biogen Idec (BIIB) | 2.0 | $3.4M | 12k | 279.75 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $3.0M | 18k | 167.28 | |
| Acceleron Pharma | 1.5 | $2.5M | 19k | 135.60 | |
| Cullinan Oncology (CGEM) | 1.5 | $2.5M | 60k | 41.67 | |
| Karyopharm Therapeutics (KPTI) | 1.4 | $2.4M | 230k | 10.52 | |
| Bluebird Bio (BLUE) | 1.4 | $2.3M | 76k | 30.15 | |
| Amarin Corp Spons Adr New (AMRN) | 1.1 | $1.9M | 300k | 6.21 | |
| Nektar Therapeutics (NKTR) | 1.1 | $1.8M | 92k | 20.00 | |
| Masimo Corporation (MASI) | 1.1 | $1.8M | 8.0k | 229.62 | |
| ImmunoGen | 0.9 | $1.5M | 190k | 8.10 | |
| Chemocentryx | 0.9 | $1.5M | 30k | 51.23 | |
| Arena Pharmaceuticals | 0.9 | $1.5M | 22k | 69.41 | |
| Progenity | 0.8 | $1.3M | 270k | 4.76 | |
| Harrow Health (HROW) | 0.7 | $1.2M | 180k | 6.75 | |
| Vanda Pharmaceuticals (VNDA) | 0.7 | $1.2M | 80k | 15.03 | |
| Corcept Therapeutics Incorporated (CORT) | 0.7 | $1.2M | 50k | 23.80 | |
| Soleno Therapeutics | 0.7 | $1.1M | 877k | 1.26 | |
| Angion Biomedica Corp | 0.7 | $1.1M | 61k | 18.06 | |
| Equitrans Midstream Corp (ETRN) | 0.6 | $1.1M | 133k | 8.16 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $1.0M | 40k | 25.70 | |
| Continental Resources | 0.6 | $999k | 39k | 25.88 | |
| Arvinas Ord (ARVN) | 0.6 | $992k | 15k | 66.13 | |
| G1 Therapeutics (GTHX) | 0.6 | $962k | 40k | 24.05 | |
| Contrafect | 0.6 | $960k | 200k | 4.80 | |
| Encana Corporation (OVV) | 0.5 | $818k | 34k | 23.81 | |
| Inari Medical Ord (NARI) | 0.4 | $749k | 7.0k | 107.00 | |
| Tg Therapeutics (TGTX) | 0.4 | $723k | 15k | 48.20 | |
| Aspira Womens Health | 0.4 | $696k | 103k | 6.75 | |
| Biohaven Pharmaceutical Holding | 0.4 | $684k | 10k | 68.40 | |
| Progyny (PGNY) | 0.4 | $668k | 15k | 44.53 | |
| Alkermes SHS (ALKS) | 0.4 | $654k | 35k | 18.69 | |
| Pioneer Natural Resources (PXD) | 0.4 | $604k | 3.8k | 158.95 | |
| Stoke Therapeutics (STOK) | 0.3 | $583k | 15k | 38.87 | |
| Xencor (XNCR) | 0.3 | $530k | 12k | 43.09 | |
| Laird Superfood (LSF) | 0.3 | $525k | 14k | 37.50 | |
| Translate Bio | 0.3 | $495k | 30k | 16.50 | |
| Amicus Therapeutics (FOLD) | 0.2 | $375k | 38k | 9.87 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $343k | 8.0k | 42.88 | |
| Inflarx Nv (IFRX) | 0.2 | $273k | 70k | 3.90 | |
| Arcutis Biotherapeutics (ARQT) | 0.2 | $260k | 9.0k | 28.89 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $259k | 10k | 25.90 | |
| Dicerna Pharmaceuticals | 0.2 | $256k | 10k | 25.60 | |
| Yield10 Bioscience | 0.1 | $238k | 19k | 12.56 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $203k | 20k | 10.15 | |
| Therapeuticsmd | 0.1 | $134k | 100k | 1.34 | |
| Concert Pharmaceuticals I equity | 0.1 | $100k | 20k | 5.00 |
